
Supriya Sharma, chief medical adviser at Health Canada, says Pfizer’s vaccine was authorized under what’s called an ‘interim order pathway,’ which gives it the flexibility to conduct a ‘rolling review’ and ‘accept information as it becomes available.’ The Hill Times photograph by Andrew Meade













